Human immunodeficiency virus 1 (HIV-1) encodes a protease (MW 21,500 g/mol) that is essential for the assembly and maturation of the virus. The protease catalyzes the hydrolysis of a heptapeptide substrate with a kcat of 1000 s-1 and a Km of 0.075 M.
a) Calculate Vmax (M/s) for substrate hydrolysis when HIV-1 protease is present at 0.20 mg/mL. Give your answer in the format 5.4 E -6 (a hypothetical example) with 2 sig figs -- do not show units.
When -C(O)NH- of the heptapeptide is replaced by -CH2NH-, the resulting derivative cannot be cleaved by HIV-1 protease and acts as an inhibitor. Under the same experimental conditions as in part (a), but in the presence of 2.5 μM inhibitor, Vmax is 9.3 × 10-3 M s-1. What kind of inhibition is occurring?
competitive inhibition
non-competitive inhibition
uncompetitive inhibition
none of these
Human immunodeficiency virus 1 (HIV-1) encodes a protease (MW 21,500 g/mol) that is essential for the...
por favor mostrar el proceso A protease (Mr = 21,500) hydrolyzes a heptapeptide substrate with a 1000 s kcat. -3 -1 When the initial substrate concentration is 0.1 M, the v0 is 5.31 x 10 Ms-1 a) Calculate vmax and this hydrolysis when the protease concentration is 0.2 mg / mL of this protease. b) Calculate Km with the previous data. c) In the presence of an inhibitor, it was found that vmax = 9.3 x 10-3 M / s....
Question 3: The HIV protease is manufactured by the virus to cleave the polyprotein into functional parts of the virion. The velocity of the HIV protease with a viral protein target without inhibitor (column 1) and with a low concentration of a target inhibitory drug (column 2), shown below. The inhibitor was made by chemically modifying the viral protein target. Sphingosine (UM) V. (mg 'min) with no inhibitor ([U] = 0) 5.00E-06 1.00E-05 2.00E-05 4.00E-05 8.00E-05 1.60E-04 4.00E-05 5.33E-05 6.40E-05...
Please help me with these two problems. I will rate the answers. 1. The HIV-1 protease, an important enzyme in the life cycle of the human immunodeficiency virus-1 (HIV-1), is a good drug target for the treatment of HIV and AIDS. A protein produced by the virus, p6*, is an HIV-1 protease inhibitor. The activity of the HIV-1 protease was measured in the presence and absence of p6* using an assay involving an artificial substrate, as shown below. NH Lys...